BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14712787)

  • 41. The impact of one or two missed doses on the duration of action of combined perindopril and indapamide.
    Myers MG; Leenen FH;
    J Hum Hypertens; 2007 Jan; 21(1):86-93. PubMed ID: 17066085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects.
    Richard V; Joannides R; Henry JP; Mulder P; Mace B; Guez D; Schiavi P; Thuillez C
    J Hypertens; 1996 Dec; 14(12):1447-54. PubMed ID: 8986928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
    Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B
    J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 47. Very-low-dose combination: a first-line choice for the treatment of hypertension?
    Waeber B
    J Hypertens Suppl; 2003 Jun; 21(3):S3-10. PubMed ID: 12929469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM
    Manag Care; 2001 Feb; 10(2 Suppl):6-10. PubMed ID: 11729406
    [No Abstract]   [Full Text] [Related]  

  • 51. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
    MMW Fortschr Med; 2005 Sep; 147(39):12. PubMed ID: 16245771
    [No Abstract]   [Full Text] [Related]  

  • 53. Prestalia--another combination for hypertension.
    Med Lett Drugs Ther; 2015 Jul; 57(1473):103-4. PubMed ID: 26204040
    [No Abstract]   [Full Text] [Related]  

  • 54. [American hypertension guidelines discussed. Are diuretics really the best first-line therapy?].
    MMW Fortschr Med; 2003 Aug; 145(31-32):50. PubMed ID: 14524075
    [No Abstract]   [Full Text] [Related]  

  • 55. Hypertension: which aspects of hypertension should we impact on and how?
    Zanchetti A; Waeber B
    J Hypertens Suppl; 2006 Aug; 24(5):S2-5. PubMed ID: 16936532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is the key.
    Anderson C
    Stroke; 2003 May; 34(5):1333-4. PubMed ID: 12702834
    [No Abstract]   [Full Text] [Related]  

  • 57. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
    Renaud IM; Chainey A; Belair MF; Mandet C; Michel O; Myara I; Chevalier J; Plante GE
    Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diuretics: drugs of choice for the initial management of patients with hypertension.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):35-41. PubMed ID: 15030295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.